Alternatives to Organ Replacement

Authors

  • Nunt Paisarntanawat Saint Joseph Convent , Silom, Bang Rak, Bangkok, 10500 Thailand

Keywords:

Mechanical support, organ transplantation, regenerative medication, three-dimensional bioprinting, xenotransplantation

Abstract

Organ replacement is the process in which an organ is replaced, this is done with the purpose of improving quality of life and helping patients suffering from damaged or malfunctioning organs, especially vital organs such as the heart, kidney, lungs, and many more that may affect a patient's health tremendously if not replaced. One of the most common and well known methods of organ transplantation is organ donation, in which an organ is removed from one body, to be placed in the patient’s that is in need of a new organ whether it be from organ malfunction or the absence of an organ. But this method comes with multiple drawbacks, such as the patient's compatibility with the donated organ, ethical and religious issues, and organ shortage that can lead to in an increase of organ trafficking, which is when organs are removed illegally and without consent to be sold in the black market as a result of high demand for organs for transplantation and other medical usage. But with today’s technology, multiple alternatives to organ donation and transplantation have emerged that provide solutions to the mentioned issues. Such as xenotransplantation, a process which involves the transplantation from one species of another, 3d bioprinting, 3d printing used to fabricate biomedical parts that imitate natural tissue, mechanical support, which involves using machines to provide support to failing organs, and other emerging technologies in development such as regenerative medicine, which can help regrow and replace tissues and organs, cloning from stem cells, and artificial organs. Although neither of these methods alone can solve the ongoing crisis as they are not ready, each method presents its own advantages and disadvantages, and should be improved and researched upon in order to find a solution closest to perfect for organ replacement.

References

R. Vanholder et al., "Organ donation and transplantation: a multi-stakeholder call to action," Nature Reviews Nephrology, vol. 17, no. 8, pp. 554-568, 2021.

R. Tamburrini and J. S. Odorico, "Pancreas transplant versus islet transplant versus insulin pump therapy: in which patients and when?," Current opinion in organ transplantation, vol. 26, no. 2, pp. 176-183, 2021.

A. Sen, "Left Ventricular Assist Devices and Pacemakers," in Emergency Department Critical Care: Springer, 2020, pp. 165-192.

J. Swol, N. Shigemura, S. Ichiba, U. Steinseifer, M. Anraku, and R. Lorusso, "Artificial lungs––Where are we going with the lung replacement therapy?," Artificial Organs, vol. 44, no. 11, pp. 1135-1149, 2020.

S. Obrecht, "Transplantation Surgery: organ Replacement Between Reductionism and Systemic Approaches," in The Palgrave Handbook of the History of Surgery: Springer, 2018, pp. 411-433.

M. Malinis, H. W. Boucher, and A. S. T. I. D. C. o. Practice, "Screening of donor and candidate prior to solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice," Clinical Transplantation, vol. 33, no. 9, p. e13548, 2019.

L. Zhao, S. Chen, P. Yang, H. Cao, and L. Li, "The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease," Stem cell research & therapy, vol. 10, no. 1, pp. 1-13, 2019.

M. J. Łos, S. Panigrahi, K. Sielatycka, and C. Grillon, "Successful biomaterial-based artificial organ—updates on artificial blood vessels," in Stem Cells and Biomaterials for Regenerative Medicine: Elsevier, 2019, pp. 203-222.

R. K. Upadhyay, "Clinical Issues Related to Safe Procurement of Organ Transplants, Its Successes, Failures and Alternatives. SF J Stem Cell 2: 1," of, vol. 13, p. 2, 2019.

D. K. C. Cooper et al., "Xenotransplantation—the current status and prospects," British Medical Bulletin, vol. 125, no. 1, p. 5, 2018.

T. Lu, B. Yang, R. Wang, and C. Qin, "Xenotransplantation: current status in preclinical research," Frontiers in immunology, vol. 10, p. 3060, 2020.

J. Arens et al., "Toward a long-term artificial lung," Asaio Journal, vol. 66, no. 8, p. 847, 2020.

M. Manyalich, H. Nelson, and F. L. Delmonico, "The need and opportunity for donation after circulatory death worldwide," Current opinion in organ transplantation, vol. 23, no. 1, pp. 136-141, 2018.

D. K. C. Cooper et al., "Justification of specific genetic modifications in pigs for clinical organ xenotransplantation," Xenotransplantation, vol. 26, no. 4, p. e12516, 2019.

C. Gouveia, C. Huyser, D. Egli, and M. S. Pepper, "Lessons learned from somatic cell nuclear transfer," International Journal of Molecular Sciences, vol. 21, no. 7, p. 2314, 2020.

M. S. Singh et al., "Retinal stem cell transplantation: Balancing safety and potential," Progress in retinal and eye research, vol. 75, p. 100779, 2020.

C. A. Schinstock et al., "Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization?," Clinical Transplantation, vol. 33, no. 12, p. e13751, 2019.

M. Molina et al., "Kidney transplant from uncontrolled donation after circulatory death donors maintained by nECMO has long‐term outcomes comparable to standard criteria donation after brain death," American Journal of Transplantation, vol. 19, no. 2, pp. 434-447, 2019.

A. Page, S. Messer, and S. R. Large, "Heart transplantation from donation after circulatory determined death," Annals of cardiothoracic surgery, vol. 7, no. 1, p. 75, 2018.

N. M. Hussain and D. Soni, "Max and Keira’s law: an overview on the advantages, disadvantages and alternatives to an opt-out organ donation system in the UK," The British Student Doctor Journal, vol. 4, no. 1, pp. 26-31, 2020.

P. Macdonald and K. Dhital, "Heart transplantation from donation-after-circulatory-death (DCD) donors: Back to the future―Evolving trends in heart transplantation from DCD donors," The Journal of Heart and Lung Transplantation, vol. 38, no. 6, pp. 599-600, 2019.

P. Ljungman et al., "Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)," The Lancet Infectious Diseases, vol. 19, no. 8, pp. e260-e272, 2019.

C. R. Wolfe, M. G. Ison, and A. S. T. I. D. C. o. Practice, "donor‐derived infections: guidelines from the American society of transplantation infectious diseases community of practice," Clinical Transplantation, vol. 33, no. 9, p. e13547, 2019.

D. K. C. Cooper et al., "Pig kidney xenotransplantation: progress toward clinical trials," Clinical Transplantation, vol. 35, no. 1, p. e14139, 2021.

A. Schaapherder et al., "Equivalent long-term transplantation outcomes for kidneys donated after brain death and cardiac death: conclusions from a nationwide evaluation," EClinicalMedicine, vol. 4, pp. 25-31, 2018.

P. Augusto and D. Messias, "Donation after circulatory death and lung transplantation," J Bras Pneumol, vol. 48, no. 2, p. e20210369, 2022.

J. Denner, "Porcine Endogenous Retroviruses and Xenotransplantation, 2021," Viruses, vol. 13, no. 11, p. 2156, 2021.

J. Denner, "Why was PERV not transmitted during preclinical and clinical xenotransplantation trials and after inoculation of animals?," Retrovirology, vol. 15, no. 1, pp. 1-9, 2018.

C. G. A. McGregor, Y. Takeuchi, L. Scobie, and G. Byrne, "PERVading strategies and infectious risk for clinical xenotransplantation," Xenotransplantation, vol. 25, no. 4, 2018.

X. Zhang et al., "The resurgent landscape of xenotransplantation of pig organs in nonhuman primates," Science China Life Sciences, vol. 64, no. 5, pp. 697-708, 2021.

A. Nellore, "Infections after xenotransplantation," Current Opinion in Organ Transplantation, vol. 23, no. 6, pp. 628-632, 2018.

J. A. Fishman, "Prevention of infection in xenotransplantation: Designated pathogen‐free swine in the safety equation," Xenotransplantation, vol. 27, no. 3, p. e12595, 2020.

H. J. Schuurman and K. Hoogendoorn, "Solid organ xenotransplantation at the interface between research and clinical development: Regulatory aspects," Xenotransplantation, vol. 27, no. 3, p. e12608, 2020.

B. Reichart, M. Längin, J. Denner, R. Schwinzer, P. J. Cowan, and E. Wolf, "Pathways to clinical cardiac xenotransplantation," Transplantation, vol. 105, no. 9, pp. 1930-1943, 2021.

J. A. Fishman, "Infectious disease risks in xenotransplantation," American Journal of Transplantation, vol. 18, no. 8, pp. 1857-1864, 2018.

A. Daugs, N. Lehmann, D. Eroglu, M. C. Meinke, A. Markhoff, and O. Bloch, "In vitro detection system to evaluate the immunogenic potential of xenografts," Tissue Engineering Part C: Methods, vol. 24, no. 5, pp. 280-288, 2018.

E. Kemter, J. Denner, and E. Wolf, "Will genetic engineering carry xenotransplantation of pig islets to the clinic?," Current diabetes reports, vol. 18, no. 11, pp. 1-12, 2018.

I. Netuka et al., "Initial bridge to transplant experience with a bioprosthetic autoregulated artificial heart," The Journal of Heart and Lung Transplantation, vol. 39, no. 12, pp. 1491-1493, 2020.

A. Soto-Gutierrez et al., "A whole-organ regenerative medicine approach for liver replacement," Tissue Engineering Part C: Methods, vol. 17, no. 6, pp. 677-686, 2011.

J. Li et al., "Development and clinical advancement of small molecules for ex vivo expansion of hematopoietic stem cell," Acta Pharmaceutica Sinica B, 2021.

N. Bhattacharya, "Xenotransplantation and its Potentials in Medicine (Volume 4, Issue 3, July-September 2020)."

M.-M. Dolmans and C. A. Amorim, "Fertility preservation: construction and use of artificial ovaries," Reproduction, vol. 158, no. 5, pp. F15-F25, 2019.

S. Takae and N. Suzuki, "Current state and future possibilities of ovarian tissue transplantation," Reproductive Medicine and Biology, vol. 18, no. 3, pp. 217-224, 2019.

M.-M. Dolmans, J. Donnez, and L. Cacciottola, "Fertility preservation: the challenge of freezing and transplanting ovarian tissue," Trends in molecular medicine, vol. 27, no. 8, pp. 777-791, 2021.

H. Li and D. J. Spade, "REPRODUCTIVE TOXICOLOGY: Environmental exposures, fetal testis development and function: phthalates and beyond," Reproduction, vol. 162, no. 5, pp. F147-F167, 2021.

F. Cargnelutti et al., "Effects of endocrine disruptors on fetal testis development, male puberty, and transition age," Endocrine, vol. 72, no. 2, pp. 358-374, 2021.

B. Reznik et al., "Heterogeneity of transposon expression and activation of the repressive network in human fetal germ cells," Development, vol. 146, no. 12, p. dev171157, 2019.

T. H. Kim et al., "Tissue-engineered vascular microphysiological platform to study immune modulation of xenograft rejection," Science Advances, vol. 7, no. 22, p. eabg2237, 2021.

A. B. Adams et al., "Xenoantigen Deletion and Chemical Immunosuppression Can Prolong Renal Xenograft Survival," Annals of surgery, vol. 268, no. 4, p. 564, 2018.

Q. Cheng et al., "Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain‐death induced immunological injury post–lung transplant," American Journal of Transplantation, vol. 18, no. 10, pp. 2417-2428, 2018.

J. Chen et al., "A potential role of TLR2 in xenograft rejection of porcine iliac endothelial cells: an in vitro study," Xenotransplantation, vol. 26, no. 5, p. e12526, 2019.

R. Washburn, G. Kaur, and J. Dufour, "Xenogeneic Sertoli cells express complement inhibitory proteins necessary for their survival of hyperacute rejection," ed: Am Assoc Immnol, 2021.

I. A. Rosales and R. B. Colvin, "The pathology of solid organ xenotransplantation," Current Opinion in Organ Transplantation, vol. 24, no. 5, pp. 535-542, 2019.

H. Watanabe et al., "GalT‐KO pig lungs are highly susceptible to acute vascular rejection in baboons, which may be mitigated by transgenic expression of hCD 47 on porcine blood vessels," Xenotransplantation, vol. 25, no. 5, p. e12391, 2018.

Y. Deng, "Efficient and Specific Analysis of Complement Regulatory Proteins in Transgenic Animals on Xenotransplantation," 2019.

G. Ailuno, G. Zuccari, S. Baldassari, F. Lai, and G. Caviglioli, "Anti-Vascular Cell Adhesion Molecule-1 nanosystems: A promising strategy against inflammatory based diseases," Journal of Nanoscience and Nanotechnology, vol. 21, no. 5, pp. 2793-2807, 2021.

K. Khaddour, C. K. Hana, and P. Mewawalla, "Hematopoietic stem cell transplantation," in StatPearls [internet]: StatPearls Publishing, 2021.

R. Al Hamed, A. H. Bazarbachi, F. Malard, J.-L. Harousseau, and M. Mohty, "Current status of autologous stem cell transplantation for multiple myeloma," Blood cancer journal, vol. 9, no. 4, pp. 1-10, 2019.

N. P. Zarandi, G. Galdon, S. Kogan, A. Atala, and H. Sadri-Ardekani, "Cryostorage of immature and mature human testis tissue to preserve spermatogonial stem cells (SSCs): a systematic review of current experiences toward clinical applications," Stem cells and cloning: advances and applications, vol. 11, p. 23, 2018.

T. Kaeuferle, R. Krauss, F. Blaeschke, S. Willier, and T. Feuchtinger, "Strategies of adoptive T-cell transfer to treat refractory viral infections post allogeneic stem cell transplantation," Journal of hematology & oncology, vol. 12, no. 1, pp. 1-10, 2019.

K. K. Maung and M. E. Horwitz, "Current and future perspectives on allogeneic transplantation using ex vivo expansion or manipulation of umbilical cord blood cells," International Journal of Hematology, vol. 110, no. 1, pp. 50-58, 2019.

R. Castagnoli, O. M. Delmonte, E. Calzoni, and L. D. Notarangelo, "Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives," Frontiers in pediatrics, vol. 7, p. 295, 2019.

M. Mohaqiq, M. Movahedin, Z. Mazaheri, and N. Amirjannati, "Successful human spermatogonial stem cells homing in recipient mouse testis after in vitro transplantation and organ culture," Cell Journal (Yakhteh), vol. 20, no. 4, p. 513, 2019.

J. B. Menendez-Gonzalez and J. Hoggatt, "Hematopoietic Stem Cell Mobilization: Current Collection Approaches, Stem Cell Heterogeneity, and a Proposed New Method for Stem Cell Transplant Conditioning," Stem cell reviews and reports, vol. 17, no. 6, pp. 1939-1953, 2021.

M. Ali, A. K. Pr, S. J. Lee, and J. D. Jackson, "Three-dimensional bioprinting for organ bioengineering: promise and pitfalls," Current opinion in organ transplantation, vol. 23, no. 6, pp. 649-656, 2018.

X. Huang and H. E. Broxmeyer, "Progress towards improving homing and engraftment of hematopoietic stem cells for clinical transplantation," Current Opinion in Hematology, vol. 26, no. 4, pp. 266-272, 2019.

X. Huang, B. Guo, M. Capitano, and H. E. Broxmeyer, "Past, present, and future efforts to enhance the efficacy of cord blood hematopoietic cell transplantation," F1000Research, vol. 8, 2019.

A. M. Patterson et al., "Prostaglandin E2 Enhances Aged Hematopoietic Stem Cell Function," Stem Cell Reviews and Reports, vol. 17, no. 5, pp. 1840-1854, 2021.

A. Sporrij et al., "Prostaglandin E2 stimulates CREB-mediated modification of histone variant nucleosomes at enhancers to promote hematopoietic stem cell fate," Blood, vol. 132, p. 530, 2018.

A. Patterson, P. A. Plett, C. Sampson, L. Pelus, and C. Orschell, "3028–ENHANCING AGED HEMATOPOIETIC STEM CELL FUNCTION WITH PROSTAGLANDIN E2," Experimental Hematology, vol. 88, p. S47, 2020.

S. Ghafouri-Fard, V. Niazi, M. Taheri, and A. Basiri, "Effect of small molecule on ex vivo expansion of cord blood hematopoietic stem cells: a concise review," Frontiers in Cell and Developmental Biology, vol. 9, p. 875, 2021.

K. M. Sullivan et al., "Myeloablative autologous stem-cell transplantation for severe scleroderma," New England Journal of Medicine, vol. 378, no. 1, pp. 35-47, 2018.

S. Matoba and Y. Zhang, "Somatic cell nuclear transfer reprogramming: mechanisms and applications," Cell stem cell, vol. 23, no. 4, pp. 471-485, 2018.

R. F. Duarte et al., "Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019," Bone marrow transplantation, vol. 54, no. 10, pp. 1525-1552, 2019.

A. Alemany, M. Florescu, C. S. Baron, J. Peterson-Maduro, and A. Van Oudenaarden, "Whole-organism clone tracing using single-cell sequencing," Nature, vol. 556, no. 7699, pp. 108-112, 2018.

E. Hoffman and K. Ishiguro, "Clone Lives," Genetics and the Literary Imagination, p. 118, 2020.

G. Gao, B. S. Kim, J. Jang, and D.-W. Cho, "Recent strategies in extrusion-based three-dimensional cell printing toward organ biofabrication," ACS Biomaterials Science & Engineering, vol. 5, no. 3, pp. 1150-1169, 2019.

M. Klak et al., "Novel strategies in artificial organ development: what is the future of medicine?," Micromachines, vol. 11, no. 7, p. 646, 2020.

E. M. Comber, R. N. Palchesko, W. H. Ng, X. Ren, and K. E. Cook, "De novo lung biofabrication: clinical need, construction methods, and design strategy," Translational Research, vol. 211, pp. 1-18, 2019.

J. Kim, K. Kang, C. J. Drogemuller, G. G. Wallace, and P. T. Coates, "Bioprinting an artificial pancreas for type 1 diabetes," Current diabetes reports, vol. 19, no. 8, pp. 1-10, 2019.

G. J. Gillispie et al., "Three-dimensional tissue and organ printing in regenerative medicine," in Principles of regenerative medicine: Elsevier, 2019, pp. 831-852.

S. J. Lee, J. B. Lee, Y.-W. Park, and D. Y. Lee, "3D bioprinting for artificial pancreas organ," Biomimetic Medical Materials, pp. 355-374, 2018.

M. Aman et al., "Bionic hand as artificial organ: Current status and future perspectives," Artificial organs, vol. 43, no. 2, pp. 109-118, 2019.

A. Soyama et al., "Efficacy of an artificial pancreas device for achieving tight perioperative glycemic control in living donor liver transplantation," Artificial Organs, vol. 43, no. 3, pp. 270-277, 2019.

V. M. Barker, "Deactivation of Pacemakers at the End of Life," Ethics & Medics, vol. 44, no. 9, pp. 1-2, 2019.

J. Barrila et al., "Modeling host-pathogen interactions in the context of the microenvironment: three-dimensional cell culture comes of age," Infection and immunity, vol. 86, no. 11, pp. e00282-18, 2018.

H. Li, Y. Yang, W. Hong, M. Huang, M. Wu, and X. Zhao, "Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects," Signal transduction and targeted therapy, vol. 5, no. 1, pp. 1-23, 2020.

F. G. Mailenova, "Transformation of ethical norms in society in the era of implementation of the latest technologies," Bioethics, vol. 21, no. 1, pp. 8-12, 2018.

S. Schnichels et al., "Retinal organ cultures as alternative research models," Alternatives to Laboratory Animals, vol. 47, no. 1, pp. 19-29, 2019.

N. Naito, K. Cook, Y. Toyoda, and N. Shigemura, "Artificial lungs for lung failure: JACC technology corner," Journal of the American College of Cardiology, vol. 72, no. 14, pp. 1640-1652, 2018.

M. Bumbaširević et al., "The current state of bionic limbs from the surgeon’s viewpoint," EFORT open reviews, vol. 5, no. 2, pp. 65-72, 2020.

D. Foord, "CHANGES IN TECHNOLOGIES AND MEANINGS OF UPPER LIMB PROSTHETICS: PART I-FROM ANCIENT EGYPT TO EARLY MODERN EUROPE," 2020.

X. Wang, "Advanced polymers for three-dimensional (3D) organ bioprinting," Micromachines, vol. 10, no. 12, p. 814, 2019.

A. J. Thompson et al., "Low-resistance, concentric-gated pediatric artificial lung for end-stage lung failure," ASAIO journal (American Society for Artificial Internal Organs: 1992), vol. 66, no. 4, p. 423, 2020.

M. Pflaum, A. S. Peredo, D. Dipresa, A. De, and S. Korossis, "Membrane bioreactors for (bio-) artificial lung," in Current Trends and Future Developments on (Bio-) Membranes: Elsevier, 2020, pp. 45-75.

R. A. Orizondo, A. J. Cardounel, R. Kormos, and P. G. Sanchez, "Artificial lungs: current status and future directions," Current Transplantation Reports, vol. 6, no. 4, pp. 307-315, 2019.

E. Cho, Y. Y. Kim, K. Noh, and S. Y. Ku, "A new possibility in fertility preservation: The artificial ovary," Journal of Tissue Engineering and Regenerative Medicine, vol. 13, no. 8, pp. 1294-1315, 2019.

M.-M. Dolmans, "From isolated follicles to the artificial ovary: Why and how?," Current Opinion in Endocrine and Metabolic Research, vol. 18, pp. 62-68, 2021.

M. C. Chiti and C. A. Amorim, "The Artificial Ovary," Fertility Preservation: Principles and Practice, p. 381, 2021.

Downloads

Published

2022-04-18

How to Cite

Nunt Paisarntanawat. (2022). Alternatives to Organ Replacement. International Journal of Formal Sciences: Current and Future Research Trends, 13(1), 87–101. Retrieved from https://ijfscfrtjournal.isrra.org/index.php/Formal_Sciences_Journal/article/view/642

Issue

Section

Articles